Misonix inc (MSON)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Operating activities
Net loss

-5,588,480

-5,088,973

1,796,492

-2,345,799

-1,589,681

-840,331

-2,610,986

-1,781,635

2,238,198

-6,856,774

-1,212,224

-

-

-

-

-

-

174,584

-219,740

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (income) from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,189

4,976

4,975

4,975

1,793

4,976

4,975

4,975

-87,367

3,356

3,475

6,318

-1,501,293

307,959

1,299,813

-204,107

-992,342

5,518

-182,868

-175,315

Net loss from operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-521,883

-

-

-

-

3,824,968

204,644

896,222

378,222

1,387,400

173,794

454,363

-888,977

-1,527,682

-700,337

-657,244

38,516

243,689

-276,414

227,946

-803,986

-458,419

-357,528

-446,409

-842,531

Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization

1,021,187

965,876

460,296

483,565

413,071

400,547

366,588

380,714

369,219

350,872

326,420

303,410

281,392

256,030

226,012

380,108

368,444

446,111

457,309

436,896

381,127

297,761

324,188

266,050

252,969

228,178

231,271

213,299

207,046

182,764

182,328

-

-

-

-

-

-

-

-

Bad debt expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,000

15,000

-

15,000

15,000

13,902

-

-

-

-

-

-

-

-

Depreciation and amortization and other non-cash items

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

182,937

171,509

169,916

191,205

138,859

136,402

35,972

Bad debt expense (recovery)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-10,000

-15,000

-44,571

7,108

-7,000

31,022

Bad debt expense (recovery)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-44,571

7,108

-7,000

31,022

Disposals of property, plant and equipment

-

-

-

-

-

-

0

-

-10,226

-16,042

-112,704

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

18,515

Bad debt expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20,000

0

-10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income tax expense

-

-

-

-

-

-

0

0

0

5,524,422

-281,000

-752,996

-130,861

-30,000

-26,000

-242,262

-49,000

-62,000

-149,000

-2,892,428

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation

482,203

404,652

345,084

446,964

384,589

500,088

1,004,498

547,807

611,127

844,601

625,293

469,933

532,341

309,984

-226,119

454,479

446,172

428,250

300,743

344,429

279,236

269,589

213,996

187,489

184,146

181,306

143,944

132,020

135,473

122,034

98,945

86,575

86,575

87,373

82,245

78,666

75,579

70,892

60,106

Release of valuation allowance on deferred tax assets

-455,000

0

-4,085,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income

-

-

-

-

-

-

0

-

-

-

6,436

4,650

-9,972

19,270

4,650

-11,886

12,269

-3,685

12,268

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred lease liability

-

-

-

-

-

-

-

-

-

-

-

-23

-23

-23

-23

-2,315

-2,316

-2,315

-2,316

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,042

-16,196

-15,592

-

910

11,396

-15,051

-15,052

942

-11,053

-11,053

-15,041

-15,040

-30,508

-34,774

-14,835

22,547

10,280

-36,008

Deferred lease liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,153

-4,154

-4,153

-

-1,799

-1,800

-1,799

204

204

204

203

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Deferred lease liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,238

-2,238

-2,238

-4,213

-4,213

-4,213

-1,404

Accounts receivable

1,221,304

210,857

1,885,808

18,678

-355,846

224,027

289,722

822,160

152,400

172,868

-979,878

776,233

586,988

-70,900

-28,359

-262,131

22,465

386,653

-788,807

963,384

-77,145

269,263

-443,407

768,872

11,519

86,652

-160,305

201,360

474,748

-268,638

-532,011

1,171,928

125,172

91,044

-276,032

472,571

-261,259

341,766

-425,892

Inventories

3,327,148

3,485,049

2,188,560

1,177,956

815,253

1,085,424

104,135

215,609

355,386

189,921

649,440

423,150

333,112

280,947

-164,073

199,684

775,307

1,013,733

834,580

462,959

320,975

-41,234

517,286

299,901

774,354

-187,221

146,590

37,632

75,818

86,333

-292,709

-395,588

715,637

368,923

-149,981

-117,729

313,898

381,713

218,969

Prepaid expenses and other current assets

370,591

511,017

-29,200

-29,408

262,700

18,438

-28,333

-165,820

703,877

-194,452

-416,438

237,185

356,945

-149,253

-40,269

-96,010

348,482

16,615

-82,876

-102,966

397,247

-88,182

-76,271

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease and other assets

-539,339

-315,627

237,938

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible and other assets

-

-

-

-

-

-

-49,282

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-109,645

-117,120

-

97,649

-60,557

-102,749

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

166,844

-191,823

-135,700

-274,399

266,388

-322,843

96,143

Accounts payable, accrued expenses and other current liabilities

471,146

-1,424,286

415,588

1,460,570

-9,719

1,829,792

-178,663

440,417

638,728

-394,908

-1,285,333

1,779,371

-239,533

312,909

64,485

489,258

-26,709

492,626

-324,293

304,285

111,703

-467,103

-361,821

591,394

288,730

-406,668

-855,675

919,092

415,056

369,031

-807,842

357,466

89,161

-759,878

-118,469

595,130

430,627

88,279

-110,427

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-233,137

Net cash used in operating activities

-7,886,828

-8,074,027

-5,350,646

-

-1,488,759

621,595

-1,734,805

-

506,105

1,470,583

-973,700

-

-1,131,418

154,100

-255,431

-

-

-

-

-

-

-

-

-

-

-

-1,240,452

-

-574,831

263,598

442,468

204,788

-938,196

-559,464

-126,117

360,088

-11,838

-744,601

-597,104

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

784,564

-1,261,544

68,570

92,170

677,397

310,438

836,272

547,232

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities
Acquisition of property, plant and equipment

93,508

98,968

112,379

95,300

103,335

197,685

287,506

17,406

240,116

32,768

85,129

250,794

72,079

58,594

108,954

61,268

82,276

243,087

85,198

123,260

36,692

150,037

35,323

11,180

-231,688

287,020

5,925

-143,896

542,227

93,279

41,629

76,886

112,338

91,613

193,440

33,975

502,061

81,432

26,927

Payments for assets acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

198,062

-198,062

129,880

129,880

-

-

-

-

Additional patents

32,801

44,744

27,149

34,937

52,807

25,025

50,080

44,750

62,459

31,776

26,403

38,638

30,581

71,054

84,121

61,190

25,337

24,908

21,296

14,795

9,576

51,606

28,778

43,991

13,079

43,581

28,427

29,543

10,404

25,270

17,505

-

-

-

-

-

-

-

-

Cash from acquisition of Solsys Medical, LLC

0

0

5,525,601

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in investing continuing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-122,458

-107,613

-267,995

-106,494

-138,055

-374,404

-201,643

-64,101

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities - discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

710,000

405,000

Additional patents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-25,225

-16,894

-

-

-

-

Payments for assets acquisition (note 10)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

129,880

800,000

0

Net cash provided by (used in) investing activities

-126,309

-143,712

5,386,073

-130,237

-156,142

-222,710

-337,586

128,961

-302,575

-64,544

-111,532

-289,668

59,201

-129,648

-193,075

-

-

-

-

-

-

-

-

-

-

-

-34,352

-

-552,631

-118,549

-59,134

-87,837

-131,917

-246,718

-340,214

-68,892

-631,941

-881,432

-26,927

Financing activities
Proceeds from notes payable

10,000,000

13,750,883

4,999,117

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock registration and investment bank fees

2,497,644

1,334,187

27,205

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of short-term borrowings

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

10,701

73,790

93,188

Principal payments on capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,939

3,869

3,800

2,236

3,688

3,621

3,557

Proceeds from exercise of stock options

10,332

1,164,248

10,836

42,357

483,835

451,590

415,747

107,845

3,671

168,350

56,202

30,145

162,600

140,847

0

38,200

3,492

11,699

136,056

167,663

427,921

58,151

69,825

121,705

232,700

13,650

116,905

133,818

191,972

43,856

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38,200

3,492

11,699

136,056

167,663

427,921

58,151

69,825

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

33,334,750

9,761,004

4,982,748

-

483,835

451,590

415,747

-

3,671

168,350

56,202

-

162,600

4,140,847

0

-

-

-

-

-

-

-

-

-

-

-

116,905

-

191,972

43,856

0

521

-3,435

-3,869

-3,800

-2,236

-14,389

-77,411

-96,745

Net cash provided by discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

7,469

249,696

4,975

4,975

1,793

254,976

4,975

4,975

-6,018

172,007

3,475

6,318

1,949,333

57,957

-175,003

-204,107

-992,342

5,518

527,132

229,685

Effect of exchange rate changes on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

3,923

Net increase (decrease) in cash and cash equivalents

25,321,613

1,543,265

5,018,175

-1,169,817

-1,161,066

850,475

-1,656,644

-1,330,176

207,201

1,574,389

-1,029,030

-299,432

-909,617

4,165,299

-448,506

692,237

-1,200,665

-187,726

121,732

714,474

613,651

697,755

557,931

1,391,738

614,674

380,013

-1,152,924

-285,127

-763,483

192,380

389,652

341,987

-765,589

489,762

-674,238

-703,382

-652,650

-1,176,312

-487,168

Supplemental disclosure of cash flow information:
Cash paid for:
Interest

582,614

803,826

10,751

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes

0

0

550

5,789

58,514

5,595

7,678

-191

0

895

0

313

7,813

0

2,053

-189

9,795

54,600

76,725

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of inventory to property, plant and equipmment for consignment of product

-

-

-

-

-

-

203,671

-

-

347,071

435,849

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Transfer of inventory to property, plant and equipment for consignment of product

1,596,309

1,206,500

733,679

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock issued for the acquisition of Solsys Medical, LLC

0

0

108,643,710

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock registration fees not paid

-

-

1,259,351

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capitalization of consigned product

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

276,009

414,979

326,518

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-19

72

151

212

280

415

1,438

3,641

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

33,398

4,376

35,794

-

5,626

10,594

856

10,071

10,821

5,514

5,935

64

9,847

4,906

5,903

6,088

0

0

42,100